Drug Shortage Report for SANDOZ REPAGLINIDE
Report ID | 64121 |
Drug Identification Number | 02357488 |
Brand name | SANDOZ REPAGLINIDE |
Common or Proper name | REPAGLINIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | REPAGLINIDE |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 tab |
ATC code | A10BX |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2018-09-27 |
Estimated end date | 2019-02-08 |
Actual end date | 2019-02-11 |
Shortage status | Resolved |
Updated date | 2019-02-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-02-18 | French | Compare |
v11 | 2019-02-18 | English | Compare |
v10 | 2019-02-06 | French | Compare |
v9 | 2019-02-06 | English | Compare |
v8 | 2019-01-16 | French | Compare |
v7 | 2019-01-16 | English | Compare |
v6 | 2018-12-18 | French | Compare |
v5 | 2018-12-18 | English | Compare |
v4 | 2018-11-06 | French | Compare |
v3 | 2018-11-06 | English | Compare |
v2 | 2018-10-15 | French | Compare |
v1 | 2018-10-15 | English | Compare |
Showing 1 to 12 of 12